Sleep to Activate Mood Promotion
STAMP
1 other identifier
interventional
12
1 country
1
Brief Summary
The investigators are aiming to examine the acceptability and feasibility of a portable bright light therapy instrument to improve sleep disturbance in a preventive intervention for depression. The investigators will conduct an intervention that trials the use of bright light glasses called "re-timers" as a preventive intervention in older adults with sleep disturbance and subsyndromal symptoms of depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable depression
Started Apr 2015
Shorter than P25 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 6, 2015
CompletedFirst Posted
Study publicly available on registry
April 9, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedResults Posted
Study results publicly available
April 7, 2017
CompletedApril 7, 2017
April 1, 2017
11 months
April 6, 2015
February 16, 2017
April 4, 2017
Conditions
Outcome Measures
Primary Outcomes (4)
Pittsburgh Sleep Quality Index
The Pittsburgh Sleep Quality Index is a validated scale which measures self-reported sleep quality based on a wide variety of questions (duration, quality, disturbances, medication, etc.) and converts them to a scale which ranges from 0 to 21 where 6 or higher denotes poor sleep quality.
two weeks after introduction of intervention
Patient Health Questionnaire-9 Depression Scale
The PHQ-9 Depression Scale is a validated scale ranging from 0 to 27 with higher numbers representing greater severity of depressive symptoms, based on 9 questions with each question on a scale of 0 - 3.
two weeks after introduction of intervention
Insomnia Severity Index Sum Scores
The Insomnia Severity Index measures insomnia severity on a scale from 0 to 28. A score of 15 or higher is indicative of clinical insomnia.
two weeks after introduction of intervention
Morningness-Eveningness Questionnaire
The morningness- eveningness categories represent the time of day when a person is at their peak alertness.
two weeks after introduction of intervention
Secondary Outcomes (11)
Actigraph Sleep Data: Minutes Asleep
daily for 4 weeks- baseline and intervention period
Actigraph: Number of Awakenings
daily for 4 weeks- baseline and intervention period
Actigraph: Efficiency
daily for 4 weeks- baseline and intervention period
Fitbit Sleep Data: Sleep Duration
daily for 4 weeks- baseline and intervention period
Fitbit Sleep Data: Night Awakenings
daily for 4 weeks- baseline and intervention period
- +6 more secondary outcomes
Study Arms (1)
Bright Light Intervention
EXPERIMENTALBefore the bright light intervention is initiated (and during the intervention), participants will wear two wrist bands which measure sleep quality and activity levels- the Fitbit and actigraphy watches. These will be worn for two weeks to assess individuals' baseline levels of sleep quality and will continue to be worn during the intervention. Following the baseline period, the re-timer glasses will be introduced and worn for a period of 30 to 50 minutes a day for two weeks.
Interventions
Participants will wear the Re-timer glasses for 30 minutes a day according to their sleep chronotype in weeks 3 and 4 of the study.
Eligibility Criteria
You may qualify if:
- years of age or older
- or greater on the Pittsburgh Sleep Quality Index
- A score of 5 to 9 on the Patient Health Questionnaire-9 Depression Scale
You may not qualify if:
- Active suicidal ideation
- Presence of mania or bipolar disorder
- Presence of an eye disease
- Prescription of a photosensitizing medication
- Having previously had eye surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Amanda Leggett
- Organization
- University of Michigan
Study Officials
- PRINCIPAL INVESTIGATOR
Amanda N Leggett, PhD
University of Michigan
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postdoctoral Research Fellow
Study Record Dates
First Submitted
April 6, 2015
First Posted
April 9, 2015
Study Start
April 1, 2015
Primary Completion
March 1, 2016
Study Completion
March 1, 2016
Last Updated
April 7, 2017
Results First Posted
April 7, 2017
Record last verified: 2017-04